View Older Stories View More Recent Stories

Feb 3, 2020 08:00AM AgeX Therapeutics to Collaborate with University of California, Irvine on Neural Stem Cell Research Program for Huntington’s Disease and Other Neurological Disorders
Jan 29, 2020 08:06AM AgeX Therapeutics Inc. (AGE) Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells
Jan 29, 2020 08:00AM AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells
Jan 14, 2020 08:00AM AgeX Therapeutics to Participate at Four Conferences in January 2020
Dec 26, 2019 08:00AM AgeX Therapeutics Announces Drawdown of Second Tranche of Loan Facility from Juvenescence Ltd.
Dec 10, 2019 08:04AM Lineage Cell Therapeutics (LCTX), AgeX Therapeutics (AGE) Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
Dec 10, 2019 08:00AM Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
Dec 10, 2019 08:00AM AgeX Therapeutics and Lineage Cell Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells
Dec 9, 2019 07:00AM AgeX Therapeutics Issues Year-End Letter to Shareholders
Nov 14, 2019 04:00PM AgeX Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
Nov 12, 2019 04:05PM Lineage Cell Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
Nov 8, 2019 06:58PM AgeX Therapeutics to Present at Investing in the Age of Longevity Conference
Oct 30, 2019 08:00AM AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform
Oct 11, 2019 08:00AM AgeX Therapeutics to Present at Metabesity 2019
Sep 9, 2019 07:00AM AgeX Therapeutics Presents at the Rodman & Renshaw Global Investment Conference
Sep 4, 2019 08:00AM AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine
Aug 14, 2019 05:16PM AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
Aug 8, 2019 04:05PM BioTime Reports Second Quarter 2019 Financial Results and Provides Business Update
Aug 5, 2019 05:26PM AgeX Therapeutics Inc. (AGE) Announces Michael H. May to Board
Aug 5, 2019 05:14PM Regenerative Medicine Leader Michael H. May Joins AgeX Board of Directors
Jul 9, 2019 08:00AM AgeX Therapeutics’ CEO Dr. Michael D. West to Present at Ending Age-Related Diseases: Investment Prospects & Advances in Research
May 15, 2019 04:05PM AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
May 1, 2019 08:00AM AgeX Therapeutics to Participate at Biotech Investing in Longevity from Aikora Health and Foresight Institute
Apr 5, 2019 08:00AM AgeX Therapeutics to Present at Master Investor Show 2019
Apr 1, 2019 04:48PM AgeX Therapeutics Reports Fourth Quarter and Annual 2018 Financial Results and Provides Business Update
Mar 22, 2019 07:00AM AgeX Therapeutics Receives $4.5 Million From Exercise of Warrants
Mar 21, 2019 07:00AM AgeX Therapeutics to Present at Undoing Aging 2019, March 28-30 in Berlin, Germany
Mar 7, 2019 07:00AM LifeMap Sciences and iCarbonX Research Shenzhen Announce Strategic Collaboration
Feb 14, 2019 08:00AM BioTime Provides Business Update Including Information on AgeX, OncoCyte and Asterias
Jan 31, 2019 08:00AM AgeX Therapeutics to Present at Longevity Leaders Conference, February 4 in London
Jan 22, 2019 08:00AM AgeX Therapeutics’ CEO Dr. Michael D. West Presents at Precision Medicine World Conference 2019
Jan 10, 2019 08:00AM LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic Partnership to Offer Leading Clinical NGS Solution to the China Market
Jan 9, 2019 08:05AM AgeX Therapeutics Inc. (AGE) Reports Publication of Data in Peer-Reviewed Journal to Advance Potential Cell Therapy AgeX-BAT1 for Type II Diabetes and Obesity
Jan 9, 2019 08:00AM AgeX Therapeutics Publishes Data in Peer-Reviewed Journal to Advance Potential Cell Therapy AgeX-BAT1 for Type II Diabetes and Obesity
Jan 4, 2019 08:00AM BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech Showcase
Jan 2, 2019 08:00AM BioTime to Present at 2019 Biotech Showcase Investor Conference on January 7, 2019
Jan 2, 2019 07:00AM AgeX Therapeutics to Present at Biotech Showcase 2019
Nov 29, 2018 08:00AM AgeX Therapeutics, Inc. to Present Keynote Address at Advanced Stem Cell & Regenerative Medicine 2018 Conference
Nov 29, 2018 07:00AM AgeX Therapeutics, Inc. Shares Commence Trading on the NYSE American
Jun 6, 2016 12:00PM Shareholders of Adventure Gold and Superior Court of Quebec Approve Arrangement with Probe Metals
May 11, 2016 08:00AM Adventure Gold Files Information Circular Seeking Shareholder Approval for Business Combination With Probe Metals
Feb 4, 2016 08:00AM Adventure Gold Commences a New Drilling Program on Its 100%-Owned Detour Quebec North Project
Jan 27, 2016 08:00AM Adventure Gold and SOQUEM Commence a First Drilling Program on Lower Detour Gold Trend
Dec 8, 2015 08:07AM Adventure Gold Closes a Private Placement
Nov 24, 2015 08:30AM Adventure Gold Closes $725,025 Private Placement
Oct 7, 2015 08:00AM Adventure Gold Options a Part of Its Detour Quebec Project to SOQUEM
Aug 19, 2015 08:00AM Adventure Gold Cuts 10.6 g/t Au Over 11.5 Metres in Channel Sampling on the New Beliveau Gold Deposit - Val-d'Or East, Quebec
Jun 29, 2015 08:00AM Adventure Gold Completes Mechanical Stripping and Drone Surveying on the New Beliveau Gold Deposit - Val-d'Or East, Quebec
Jun 4, 2015 09:00AM Adventure Gold Outlines Promising IP Anomalies Along the Lower Detour Gold Trend and Releases Results from its First Drill Program on the Detour Quebec Properties
Apr 29, 2015 08:00AM Adventure Gold and GFK Resources Amend the Casa-Cameron Option Agreement and Announce 2015 Exploration Program
View More Recent Stories View Older Stories